INTRODUCTION
Removal of impacted third molar is the most commonly performed surgical procedure by oral and maxillofacial surgeons. Local anesthetic agents are the mainstay of intraoperative pain control for most office-based oral surgical procedures. Their introduction has revolutionized the practice of dentistry and allowed for a safer pain-free surgical experience. The selection of local anesthetic agent mainly depends upon its potency, latency, and duration. Lidocaine, amide type revolutionized pain control
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in regional anesthesia by replacing procaine and other closely related ester-type compounds. 1 Lidocaine as compared with procaine, is more potent, with significantly rapid onset of action, profound anesthesia, and longer duration of action. When associated with adrenaline, it has short onset (2-3 minutes) and intermediate duration (60 minutes at pulpal level, 180-300 minutes in soft tissues). 1 Because of its potency, safety, and effectiveness, lidocaine has become the gold standard for comparison among the newer agents. Newer amide local anesthetic, articaine, is a safe and effective anesthetic used in clinical dentistry since the last two decades. Due to the presence of a thiophenic ring with additional ester group in substitution with aromatic ring, the chemical structure has different properties as compared with other local anesthetic. Because of this, articaine provides increased lipid solubility, intrinsic potency (1.5 times greater than that of lidocaine), as well as greater plasma protein binding (approximately 95%). 2, 3 The duration of anesthesia of 4% articaine with epinephrine (1:200,000) for mandibular block directly depends upon its protein-binding capacity (45-60 minutes at pulpal level and 120-300 minutes on soft tissues) and onset of action is 2 to 3 minutes. 1 Thus, a study was planned to evaluate the safety and efficacy of 4% articaine with epinephrine (1:200,000) vs 2% lidocaine with epinephrine (1:200,000) during surgical removal of impacted mandibular third molars.
MATERIALS AND METHODS
The present study was performed in the Department of Oral and Maxillofacial Surgery at Sri Guru Ram Das Institute of Dental Sciences and Research, Amritsar, on 20 patients, with bilateral impacted mandibular third molars. Patients belonging to ASA class I, of the age group between 18 and 30 years with no systemic illness and having healthy dental and periodontal status were included.
Methodology
A standardized protocol was followed for the surgical removal of third molars. Surgery was carried out under strict aseptic conditions. Each patient underwent similar surgical procedure for the removal of bilateral impacted third molar in two separate visits. The time interval between the two surgical procedures in a single patient was at least 4 weeks. For the first time, patients were selected to receive either 4% articaine or 2% lidocaine (both with epinephrine 1:200,000) randomly. At the subsequent surgery, other local anesthetic agent was administered in a crossed manner.
• Each patient received a total of 3.6 mL of anesthetic solution; 1.8 mL of the solution was used for achieving regional anesthetic blockade of inferior alveolar nerve and lingual nerve. After adequate anesthesia had been achieved, another 1.8 mL solution was used for buccal nerve anesthesia and infiltration in the mucosa for the purpose of hemostasis in both the groups. If a patient complains of pain during surgery, additional local anesthetic was injected. A bayonet-shaped flap was made on the surgical side. After tooth removal, the surgical site was thoroughly irrigated, hemostasis was achieved, and suturing was done using 3/0 silk. • Patients were observed in the clinic for the first postoperative hour.
• The duration of surgery was noted from the time of placement of the incision till the time when the last suture was given.
Patients were prescribed Tab. Augmentin 625 mg TDS (Amoxicillin 500 mg + Clavulanic acid 125 mg; GlaxoSmithKline) and Tab. Brufen 600 mg TDS (Ibuprofen 600 mg; Abbott India), for 5 days postoperatively. Tab. paracetamol 500 mg was used as rescue analgesic medicine and the patients were asked to note down the number of tablets required, if any, to relieve pain.
Intraoperative and Postoperative Evaluation
The following parameters were assessed:
• Total amount (in mL) of anesthetic solution used during the surgery • Onset of action of anesthetic agent, evaluated as tingling and numbness of lower lip, corresponding half of the tongue and mucosa (reported by the patient).
• The duration of anesthesia was recorded as the time from initial patient perception of the anesthetic effect to the moment when the effect began to fade. • Need to reanesthetize the surgical zone: specifying the amount of anesthetic solution used and the technique of injection.
• Duration of postoperative analgesia (in minutes) evaluated as the period between the end of the surgery and the ingestion of the first brufen tablet for pain relief.
• Incidence, type, and severity of adverse reactions: Any findings suggestive of effect on cardiovascular and central nervous system like nervousness, dizziness, tremors, blurred eyes, etc., during the surgery and during the first postoperative hour.
• Quality of the anesthesia provided by the local anesthetic during the surgery and evaluated by the surgeon, according to the eight-point category rating scale (Table 1) , as described by Sisk. • Systolic, diastolic, and mean arterial pressure, heart rate, and oxygen saturation were noted during the surgery and after suturing. During the surgery, two measurements were made: one immediately after the regional anesthetic blockage and another 5 minutes later.
The data obtained were analyzed statistically to evaluate the efficacy of both the local anesthetic agents used during surgical removal of mandibular third molars.
Statement of Institutional Review Board
This study followed Declaration of Helsinki on medical protocol and ethics and the regional Ethical Review Board and was approved by the Institutional Review Board.
RESULTS
In the present study, comparison of mean volume of both the anesthetic solutions used showed a statistically nonsignificant difference. Volume of lidocaine used was slightly more (3.815 mL) as compared with the articaine (3.725 mL). In our study, statistically significant difference was found regarding the mean onset of action (p-value 0.011) as illustrated in Table 2 . The mean duration of anesthetic effect of articaine (141.20 ± 36.15 minutes) was significantly longer (p-value < 0.001), and articaine provided a significantly longer period of postoperative analgesia (p-value 0.017),* as given in Table 2 .
Quality of anesthesia was scored as 1 in 85% of patients in articaine group and 65% patients in the lidocaine group. In our study, no significant difference in the mean perioperative and postoperative pain scores was observed between both the anesthetic solutions as shown in Table 3 .
In our study, there were no consistent changes in vital signs (systolic blood pressure, diastolic blood pressure, and mean arterial pressure, heart rate, and oxygen saturation) observed at baseline, right after injection of the local anesthetic, 5 minutes later, or at the end of the surgical procedure for both treatment groups. Although transient increase and decrease in blood pressure, heart rate, and oxygen saturation were observed, these changes were not clinically and statistically significant between both the anesthetic groups as illustrated in Tables 4 to 6. Pain during procedure beginning after first injection. No pain after second injection Limited success (4) Pain during procedure beginning after first injection. Pain also during procedure after second injection, but procedure completed without third injection Limited success (5) Pain during procedure beginning after two injections, but surgery completed without third injection Failure (6) Pain during procedure after first injection. Pain also during procedure after second injection. Third injection required Failure (7) Pain during procedure beginning after two injections. Third injection required Failure (8) No anesthesia after two injections. Third injection required or treatment suspended 0.017* *Significant; **Highly significant; SD: Standard deviation; In all the three parameters (onset of action, duration of anesthesia, and postoperative analgesia) data were analyzed using unpaired "t" test 13.00 ± 5.94 0-20 14.75 ± 6.38 0-30 0.375 NS NS: nonsignificant; n = Total no. of patients; SD: Standard deviation; The data were analyzed using unpaired t-test and no statistically significant difference was found (p = 0.375) in the mean postoperative pain scores in both the anesthetic groups
DISCUSSION
The comparison of the mean volume of both the anesthetic solutions used showed a statistically nonsignificant difference, although the volume of lidocaine used was slightly more (3.815 mL) as compared with the articaine (3.725 mL). This is explained by the fact that additional anesthesia was required in more number of patients of lidocaine group (25%) as compared with (10%) patients of articaine group. Our results are supported by Rebolledo et al 3 who found that the average volume of 2% lidocaine with epinephrine 1:100,000 was 1.7 times greater than that of 4% articaine with epinephrine 1:100,000 but the results were found to be statistically nonsignificant. They explained this difference in volume based on the fact that the number of repeat anesthetic procedures was greater when using 2% lidocaine as compared with 4% articaine group. Malamed et al 2 also reported a nonsignificant difference regarding the volume of 2% lidocaine with epinephrine 1:100,000 (2.6 mL ± 0.09 Standard error of mean (SEM), 4.5 mL ± 0.21 SEM) and 4% articaine 1:100,000 (2.5 mL ± 0.07 SEM, 4.2 mL ± 0.15 SEM), when used for simple and complex procedures respectively. Various factors affect the onset of anesthetic solution, such as the intrinsic properties of the drug, technique used, and its pKa value; smaller the pKa, shorter the latency. As the articaine has less pKa value as compared with the lidocaine, it has a short latent period. 5 In our study, the mean onset of action of 4% articaine with epinephrine (1:200,000) was found to be 54.10 seconds (0.90 minutes) as compared with the 73.50 seconds (1.22 minutes) for 2% lidocaine with epinephrine (1:200,000). A statistically significant difference was found regarding the mean onset of action between the articaine group (54.10 seconds) and lignocaine (73.50 seconds), meaning thereby a higher latency period for lignocaine as compared with articaine. Our results are in agreement with Rebolledo et al, 3 who also found a higher latency period for 2% lidocaine with epinephrine 1:100,000 (1.25 minutes) The data were analyzed by using paired t-test but the intragroup variations in mean systolic blood pressure were found to be statistically nonsignificant (p > 0.05). The intergroup comparison of mean systolic blood pressure of articaine vs lidocaine was analyzed using unpaired t-test and the difference in the mean systolic blood pressure was found to be statistically nonsignificant (p > 0.05) between both the anesthetic groups The intragroup evaluation of mean arterial pressure for both the anesthetic solutions was analyzed using paired t-test and the difference in mean arterial pressure was found to be statistically nonsignificant (p > 0.05) for both the anesthetic solutions The duration of anesthesia depends upon its degree of protein binding, injection site, and the concentration of vasoconstrictor added in the solution. Articaine has the greatest protein-binding values among other amides. In the literature, the protein-binding capacity for lidocaine and articaine is 65 and 95% respectively. 8 In the present study, the mean duration of anesthesia of 4% articaine with epinephrine 1:200,000 (141.20 ± 36.15 minutes) was significantly longer as compared with 2% lidocaine with epinephrine 1:200,000 (97.85 ± 24.86 minutes). Ram and Amir 8 compared 4% articaine with epinephrine 1:200,000 with 2% lidocaine with epinephrine 1:100,000 in pediatric dental patients and found that the duration of soft tissues anesthesia was significantly longer for articaine (223 minutes) than for lidocaine (180 minutes). Rebolledo et al 3 compared the anesthetic efficacy of 4% articaine with that of 2% lidocaine, both with epinephrine 1:100,000 and also found that the mean duration of anesthetic effect of articaine was significantly longer than the lidocaine group. Postoperative pain control has been a point of debate since many years because it interferes with patients' quality of life. Our results demonstrated that 4% articaine provides a significantly longer period of postoperative analgesia (231.70 ± 78.89 minutes), which is explained by its ability to readily diffuse through due to the presence of a thiophene group in the molecules, which increases its lipid solubility. Our findings regarding postoperative analgesia with the use of articaine are in agreement with the findings of Colombini et al, 9 Santos et al, 10 and
Gregorio et al. 6 Our results with the use of lidocaine are supported by Giovannitti and Bennett , 11 who found that postoperative analgesia lasted for 192.5 minutes. Quality of anesthesia was evaluated according to the eight-point category rating scale in our study. Our results indicated that both the local anesthetics were successful in providing the anesthesia during surgery. However, 4% articaine with epinephrine 1:200,000 was more successful (quality of anesthesia was scored as 1 in 85% of patients in articaine group as compared with 65% patients in lidocaine group) as compared with 2% lidocaine with epinephrine 1:200,000. Our findings for the lidocaine are similar to that of Sisk, 4 who also reported that the 2% lidocaine with epinephrine 1:100,000 was successful in providing the anesthesia during the surgery. Further, Giovannitti and Bennett 11 reported that the quality of anesthesia produced by 2% lidocaine with epinephrine 1:100,000 was rated as successful in all the 28 inferior alveolar nerve blocks, given in their study. Also comparable results have been reported by Gregorio et al, 6 and
Santos et al, 10 who found that the mean scores for quality of anesthesia were close to 1 with the use of 4% articaine with epinephrine 1:200,000.
In the present study, subjective evaluation of both the intraoperative and postoperative pain was made by means of a 100-mm VAS. The VAS has been used by many authors for the subjective evaluation of pain. 2, 3, 9, [12] [13] [14] [15] The primary end point of our study was the subjective evaluation of pain during the surgical procedure. In our study, the anesthetic efficacy of articaine was demonstrated by the low mean intraoperative pain scores than the lidocaine, but no significant difference in the mean perioperative pain scores was observed between both the anesthetic solutions. Our results are supported by Malamed et al 2, 16 and Rebolledo et al 3 who in their study also found no significant difference in the mean intraoperative VAS pain scores. In this study, the postoperative pain evaluation also showed no significant difference between both the anesthetic groups. Our results are supported by Oliveira et al 13 and Rosenberg et al 14 who also observed no statistically significant differences in the VAS scores of postoperative pain with the use of 4% articaine and 2% lidocaine (both with epinephrine 1:100,000). Our findings for articaine are in agreement with Colombini et al 9 who also reported the low scores of pain (under 10 mm) in their comparative study of efficacy of 4% articaine vs 2% mepivacaine both with epinephrine (1:100,000) in postoperative analgesia for lower third molar removal. Evaluation of vital parameters (oxygen saturation, systolic and diastolic blood pressure, mean arterial pressure, and heart rate) is important during any surgical procedure. Basic monitoring provides essential information for assessing the principal vital signs, both circulatory and respiratory, and fundamentally comprises the control of blood pressure (through sphygmomanometry), heart rate, and rhythm. 17 In dentistry, local anesthetics produce limited and safe hemodynamic effects. The rates of blood pressure and serum oxygen saturation are due to endogenous catecholamines or because of adrenaline used in local anesthetic. 18 In our study, vital parameters were analyzed before surgery, during surgery, and after suturing. No consistent changes in vital signs were observed at baseline, after injection, 5 minutes later, or at the end of the surgical procedure for both treatment groups. Although transient changes were observed, these changes were not clinically and statistically significant between both the anesthetic groups. Our results are in agreement with the study conducted by Malamed et al 16 and Santos et al, 10 who compared the use of 4% articaine in association with 1:100,000 or 1:200,000 epinephrine in lower third molar removal. They also observed transient changes in hemodynamic parameters which were neither clinically significant nor attributable to the type of anesthetic solution used. Vasconcellos et al 18 studied the effect of 2% lidocaine with 1:100,000 adrenaline, 3% prilocaine with 0.03 IU felypressin, 2% mepivacaine, and 4% articaine both with 1:100,000 adrenaline in patients undergoing surgical removal of third molars and evaluated the changes in heart rate, oxygen saturation and systolic, diastolic, and mean blood pressure. Significant decrease in the diastolic blood pressure with lidocaine and increase in systolic blood pressure with mepivacaine and articaine were noted. A significant increase in heart rate from baseline to postanesthesia and a decrease in heart rate from postanesthesia to end of surgery were observed in all the groups and with all the anesthetic solutions except prilocaine. However, all the hemodynamic parameters returned to normal with no need for any further treatment.
Another parameter compared in our study was the incidence, type, and severity of adverse reactions during surgery and during the first postoperative hour. In the present study, no adverse reactions were observed perioperatively and postoperatively for both the anesthetic solutions. Colombini et al 9 and Santos et al 10 have also reported no adverse reactions with the use of articaine as a local anesthetic. Giovannitti and Bennett 11 in their study on the use of 2% lidocaine with epinephrine 1:100,000 in surgical removal of third molars also did not report any side effects or adverse reactions of the local anesthetic agent. Our results are not supported by Malamed et al 16 ;
they, however, have reported adverse reactions both with articaine and lidocaine including paresthesia, hyperesthesia, headache, infection, rash, pain, and dizziness.
